The company's hugely successful Covid shot sent the stock sky-high, but its hefty valuation comes with some big risks.
Declaring victory too soon is an excellent way to return to new heights.
The data suggest all of them court trouble by jumping the gun.
Health care stocks soared on news of Joe Biden's over performance in the Super Tuesday primaries.
After a ringing regulatory endorsement, Amarin’s Vascepa looks as if it will become available to more patients.
Biden's plan could boost the affordability and accessibility of Affordable Care Act insurance policies.
Obamacare is the Rasputin of government programs because it can’t be killed, but it’s on thin ice.
Given how well the decision to bail on the ACA has paid off, UnitedHealth should at least consider an eventual return.
Please log back in before proceeding.
There was an error logging in. Please try again.
Congrats! You are now logged in. Your exam is being submitted.
